Hot Features
プレミアム
KalVista Pharmaceuticals Inc (KALV)
NASDAQ
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-27 | Dr. Christopher M. YeaChief Development Officer | -33.80k | 666.26k | Derivative Exercise and Sale | 7.07 - 26.78 | 229.92k | - |
| 2026-05-22 | Dr. Paul K. AudhyaChief Medical Officer | -2.24k | 59.96k | Derivative Exercise and Sale | 26.78 | 150.26k | - |
| 2026-05-22 | Ms. Nicole SweenyChief Commercial Officer | 3.51k | 0.00 | Derivative Exercise and Retained Stock | - | 59.29k | 6.29% |
| 2026-05-22 | Dr. Christopher M. YeaChief Development Officer | 1.16k | 0.00 | Derivative Exercise and Retained Stock | - | 229.92k | 0.51% |
| 2026-05-22 | Dr. Paul K. AudhyaChief Medical Officer | 2.76k | 0.00 | Derivative Exercise and Retained Stock | - | 150.26k | 1.87% |
| 2026-05-22 | Ms. Nicole SweenyChief Commercial Officer | -1.49k | 39.87k | Derivative Exercise and Sale | 26.78 | 59.29k | - |
| 2026-05-22 | Dr. Christopher M. YeaChief Development Officer | -1.97k | 52.65k | Derivative Exercise and Sale | 26.78 | 229.92k | - |
| 2026-05-21 | Mr. Benjamin L. PalleikoCEO & Director | 12.32k | 0.00 | Derivative Exercise and Retained Stock | - | 479.99k | 2.64% |
| 2026-05-21 | Mr. Benjamin L. PalleikoCEO & Director | -10.93k | 292.65k | Derivative Exercise and Sale | 26.78 | 479.99k | - |
| 2026-05-21 | Ms. Nicole SweenyChief Commercial Officer | 4.39k | 0.00 | Derivative Exercise and Retained Stock | - | 55.78k | 8.54% |
| 2026-05-21 | Ms. Nicole SweenyChief Commercial Officer | -1.86k | 49.85k | Derivative Exercise and Sale | 26.78 | 55.78k | - |
| 2026-05-21 | Dr. Christopher M. YeaChief Development Officer | 1.39k | 0.00 | Derivative Exercise and Retained Stock | - | 228.76k | 0.61% |
| 2026-05-21 | Dr. Christopher M. YeaChief Development Officer | -2.36k | 63.16k | Derivative Exercise and Sale | 26.78 | 228.76k | - |
| 2026-05-21 | Mr. Brian PiekosCFO | 3.51k | 0.00 | Derivative Exercise and Retained Stock | - | 21.66k | 19.34% |
| 2026-05-21 | Mr. Brian PiekosCFO | -1.49k | 39.88k | Derivative Exercise and Sale | 26.78 | 21.66k | - |
| 2026-05-21 | Dr. Paul K. AudhyaChief Medical Officer | 3.57k | 0.00 | Derivative Exercise and Retained Stock | - | 147.50k | 2.48% |
| 2026-05-21 | Dr. Paul K. AudhyaChief Medical Officer | -2.69k | 71.92k | Derivative Exercise and Sale | 26.78 | 147.50k | - |
| 2026-05-06 | Frazier Life Sciences Management, LP法人 | -3.13M | 83.87M | 売り | 26.77 - 26.78 | 1.83M | -63.13% |
| 2026-05-17 | Dr. Christopher M. YeaChief Development Officer | 666.00 | 0.00 | Derivative Exercise and Retained Stock | - | 227.37k | 0.29% |
| 2026-05-17 | Dr. Christopher M. YeaChief Development Officer | -1.11k | 29.65k | Derivative Exercise and Sale | 26.76 | 227.37k | - |
| 2026-05-17 | Dr. Paul K. AudhyaChief Medical Officer | 1.39k | 0.00 | Derivative Exercise and Retained Stock | - | 143.93k | 0.97% |
| 2026-05-17 | Dr. Paul K. AudhyaChief Medical Officer | -1.03k | 27.62k | Derivative Exercise and Sale | 26.76 | 143.93k | - |
| 2026-05-17 | Mr. Benjamin L. PalleikoCEO & Director | 1.29k | 0.00 | Derivative Exercise and Retained Stock | - | 467.67k | 0.28% |
| 2026-05-17 | Mr. Benjamin L. PalleikoCEO & Director | -1.13k | 30.21k | Derivative Exercise and Sale | 26.76 | 467.67k | - |
| 2026-05-11 | Mr. Benjamin L. PalleikoCEO & Director | 3.80k | 0.00 | Derivative Exercise and Retained Stock | - | 466.38k | 0.82% |
| 2026-05-11 | Mr. Benjamin L. PalleikoCEO & Director | -3.32k | 88.73k | Derivative Exercise and Sale | 26.71 | 466.38k | - |
| 2026-04-16 | Ms. Nicole SweenyChief Commercial Officer | 4.39k | 0.00 | Derivative Exercise and Retained Stock | - | 51.39k | 9.34% |
| 2026-04-16 | Ms. Nicole SweenyChief Commercial Officer | -1.86k | 37.64k | Derivative Exercise and Sale | 20.22 | 51.39k | - |
| 2026-04-16 | Dr. Paul K. AudhyaChief Medical Officer | 3.56k | 0.00 | Derivative Exercise and Retained Stock | - | 142.55k | 2.56% |
| 2026-04-16 | Dr. Paul K. AudhyaChief Medical Officer | -2.69k | 54.30k | Derivative Exercise and Sale | 20.22 | 142.55k | - |
| 2026-04-16 | Mr. Brian PiekosCFO | 4.39k | 0.00 | Derivative Exercise and Retained Stock | - | 18.15k | 31.88% |
| 2026-04-16 | Mr. Brian PiekosCFO | -1.86k | 37.64k | Derivative Exercise and Sale | 20.22 | 18.15k | - |
| 2026-04-16 | Mr. Benjamin L. PalleikoCEO & Director | 10.76k | 0.00 | Derivative Exercise and Retained Stock | - | 462.58k | 2.38% |
| 2026-04-16 | Mr. Benjamin L. PalleikoCEO & Director | -9.55k | 193.07k | Derivative Exercise and Sale | 20.22 | 462.58k | - |
| 2026-03-25 | VR Management, LLC法人 | -214.63k | 3.69M | 売り | 16.95 - 19.12 | 5.09M | -4.05% |
| 2026-03-06 | Mr. Benjamin L. PalleikoCEO & Director | 8.93k | 0.00 | Derivative Exercise and Retained Stock | - | 451.82k | 2.02% |
| 2026-03-06 | Mr. Benjamin L. PalleikoCEO & Director | -6.69k | 107.63k | Derivative Exercise and Sale | 16.08 | 451.82k | - |
| 2026-02-21 | Dr. Paul K. AudhyaChief Medical Officer | 5.90k | 0.00 | Derivative Exercise and Retained Stock | - | 138.98k | 4.43% |
| 2026-02-21 | Dr. Paul K. AudhyaChief Medical Officer | -5.35k | 83.34k | Derivative Exercise and Sale | 15.57 | 138.98k | - |
| 2026-02-21 | Mr. Benjamin L. PalleikoCEO & Director | 13.22k | 0.00 | Derivative Exercise and Retained Stock | - | 442.88k | 3.08% |
| 2026-02-21 | Mr. Benjamin L. PalleikoCEO & Director | -10.03k | 156.20k | Derivative Exercise and Sale | 15.57 | 442.88k | - |
| 2026-02-21 | Ms. Nicole SweenyChief Commercial Officer | 7.28k | 0.00 | Derivative Exercise and Retained Stock | - | 47.00k | 18.31% |
| 2026-02-22 | Ms. Nicole SweenyChief Commercial Officer | -3.98k | 61.88k | Derivative Exercise and Sale | 15.57 | 47.00k | - |
| 2026-02-21 | Dr. Christopher M. YeaChief Development Officer | 2.53k | 0.00 | Derivative Exercise and Retained Stock | - | 226.70k | 1.13% |
| 2026-02-21 | Dr. Christopher M. YeaChief Development Officer | -4.35k | 67.67k | Derivative Exercise and Sale | 15.57 | 226.70k | - |
| 2026-02-21 | Mr. Brian PiekosCFO | 3.23k | 0.00 | Derivative Exercise and Retained Stock | - | 13.76k | 30.71% |
| 2026-02-21 | Mr. Brian PiekosCFO | -1.77k | 27.51k | Derivative Exercise and Sale | 15.57 | 13.76k | - |
| 2026-02-17 | Dr. Paul K. AudhyaChief Medical Officer | 1.26k | 0.00 | Derivative Exercise and Retained Stock | - | 133.09k | 0.95% |
| 2026-02-17 | Dr. Paul K. AudhyaChief Medical Officer | -1.16k | 17.45k | Derivative Exercise and Sale | 15.00 | 133.09k | - |
| 2026-02-17 | Mr. Benjamin L. PalleikoCEO & Director | 1.38k | 0.00 | Derivative Exercise and Retained Stock | - | 429.67k | 0.32% |
| 2026-02-17 | Mr. Benjamin L. PalleikoCEO & Director | -1.04k | 15.57k | Derivative Exercise and Sale | 15.00 | 429.67k | - |
| 2026-02-17 | Dr. Christopher M. YeaChief Development Officer | 665.00 | 0.00 | Derivative Exercise and Retained Stock | - | 224.17k | 0.30% |
| 2026-02-17 | Dr. Christopher M. YeaChief Development Officer | -1.11k | 16.64k | Derivative Exercise and Sale | 15.00 | 224.17k | - |
| 2026-02-11 | Mr. Benjamin L. PalleikoCEO & Director | 3.77k | 0.00 | Derivative Exercise and Retained Stock | - | 428.29k | 0.89% |
| 2026-02-11 | Mr. Benjamin L. PalleikoCEO & Director | -3.35k | 52.66k | Derivative Exercise and Sale | 15.70 | 428.29k | - |
| 2025-12-06 | Mr. Benjamin L. PalleikoCEO & Director | 8.33k | 0.00 | Derivative Exercise and Retained Stock | - | 424.52k | 2.00% |
| 2025-12-06 | Mr. Benjamin L. PalleikoCEO & Director | -7.29k | 120.42k | Derivative Exercise and Sale | 16.51 | 424.52k | - |
| 2025-11-21 | Ms. Nicole SweenyChief Commercial Officer | 7.44k | 0.00 | Derivative Exercise and Retained Stock | - | 39.73k | 23.03% |
| 2025-11-22 | Ms. Nicole SweenyChief Commercial Officer | -3.81k | 51.29k | Derivative Exercise and Sale | 13.45 | 39.73k | - |
| 2025-11-21 | Mr. Brian PiekosCFO | 10.53k | 0.00 | Derivative Exercise and Retained Stock | - | 10.53k | - |
| 2025-11-21 | Mr. Brian PiekosCFO | -4.47k | 60.14k | Derivative Exercise and Sale | 13.45 | 10.53k | - |
| 2025-11-21 | Dr. Christopher M. YeaChief Development Officer | 2.54k | 0.00 | Derivative Exercise and Retained Stock | - | 223.51k | 1.15% |
| 2025-11-21 | Dr. Christopher M. YeaChief Development Officer | -4.33k | 58.26k | Derivative Exercise and Sale | 13.45 | 223.51k | - |
| 2025-11-21 | Dr. Paul K. AudhyaChief Medical Officer | 5.95k | 0.00 | Derivative Exercise and Retained Stock | - | 131.83k | 4.73% |
| 2025-11-21 | Dr. Paul K. AudhyaChief Medical Officer | -5.30k | 71.24k | Derivative Exercise and Sale | 13.45 | 131.83k | - |
| 2025-11-21 | Mr. Benjamin L. PalleikoCEO & Director | 12.31k | 0.00 | Derivative Exercise and Retained Stock | - | 416.19k | 3.05% |
| 2025-11-21 | Mr. Benjamin L. PalleikoCEO & Director | -10.94k | 147.15k | Derivative Exercise and Sale | 13.45 | 416.19k | - |
| 2025-11-20 | Dr. Christopher M. YeaChief Development Officer | 87.39k | 375.78 | Derivative Exercise and Retained Stock | 0.00 | 220.96k | 65.42% |
| 2025-11-17 | Mr. Benjamin L. PalleikoCEO & Director | 4.90k | 0.00 | Derivative Exercise and Retained Stock | - | 403.88k | 1.23% |
| 2025-11-17 | Mr. Benjamin L. PalleikoCEO & Director | -4.47k | 64.67k | Derivative Exercise and Sale | 14.48 | 403.88k | - |
| 2025-11-17 | Dr. Christopher M. YeaChief Development Officer | 1.52k | 0.00 | Derivative Exercise and Retained Stock | - | 133.57k | 1.15% |
| 2025-11-17 | Dr. Christopher M. YeaChief Development Officer | -2.68k | 38.85k | Derivative Exercise and Sale | 14.48 | 133.57k | - |
| 2025-11-17 | Dr. Paul K. AudhyaChief Medical Officer | 3.37k | 0.00 | Derivative Exercise and Retained Stock | - | 125.88k | 2.75% |
| 2025-11-17 | Dr. Paul K. AudhyaChief Medical Officer | -3.08k | 44.52k | Derivative Exercise and Sale | 14.48 | 125.88k | - |
| 2025-11-11 | Mr. Benjamin L. PalleikoCEO & Director | 3.79k | 0.00 | Derivative Exercise and Retained Stock | - | 398.98k | 0.96% |
| 2025-11-11 | Mr. Benjamin L. PalleikoCEO & Director | -3.33k | 38.44k | Derivative Exercise and Sale | 11.55 | 398.98k | - |
| 2025-11-01 | Frazier Life Sciences Management, LP法人 | 973.45k | 0.00 | 買い | - | 3.47M | 39.05% |
| 2025-09-06 | Mr. Benjamin L. PalleikoCEO & Director | 8.33k | 0.00 | Derivative Exercise and Retained Stock | - | 395.19k | 2.15% |
| 2025-09-06 | Mr. Benjamin L. PalleikoCEO & Director | -7.29k | 115.54k | Derivative Exercise and Sale | 15.84 | 395.19k | - |
| 2025-08-22 | Ms. Nicole SweenyChief Commercial Officer | 3.52k | 0.00 | Derivative Exercise and Retained Stock | - | 32.29k | 12.23% |
| 2025-08-22 | Ms. Nicole SweenyChief Commercial Officer | -1.48k | 19.86k | Derivative Exercise and Sale | 13.42 | 32.29k | - |
| 2025-08-22 | Dr. Christopher M. YeaChief Development Officer | 1.17k | 0.00 | Derivative Exercise and Retained Stock | - | 132.05k | 0.89% |
| 2025-08-22 | Dr. Christopher M. YeaChief Development Officer | -1.95k | 26.22k | Derivative Exercise and Sale | 13.42 | 132.05k | - |
| 2025-08-22 | Dr. Paul K. AudhyaChief Medical Officer | 2.66k | 0.00 | Derivative Exercise and Retained Stock | - | 122.51k | 2.22% |
| 2025-08-22 | Dr. Paul K. AudhyaChief Medical Officer | -2.34k | 31.35k | Derivative Exercise and Sale | 13.42 | 122.51k | - |
| 2025-08-21 | Ms. Nicole SweenyChief Commercial Officer | 4.39k | 0.00 | Derivative Exercise and Retained Stock | - | 28.77k | 17.99% |
| 2025-08-21 | Ms. Nicole SweenyChief Commercial Officer | -1.86k | 24.65k | Derivative Exercise and Sale | 13.22 | 28.77k | - |
| 2025-08-21 | Dr. Christopher M. YeaChief Development Officer | 1.39k | 0.00 | Derivative Exercise and Retained Stock | - | 130.88k | 1.07% |
| 2025-08-21 | Dr. Christopher M. YeaChief Development Officer | -2.36k | 31.23k | Derivative Exercise and Sale | 13.22 | 130.88k | - |
| 2025-08-21 | Dr. Paul K. AudhyaChief Medical Officer | 3.31k | 0.00 | Derivative Exercise and Retained Stock | - | 119.84k | 2.84% |
| 2025-08-21 | Dr. Paul K. AudhyaChief Medical Officer | -2.94k | 38.90k | Derivative Exercise and Sale | 13.22 | 119.84k | - |
| 2025-08-21 | Mr. Benjamin L. PalleikoCEO & Director | 12.31k | 0.00 | Derivative Exercise and Retained Stock | - | 386.86k | 3.29% |
| 2025-08-21 | Mr. Benjamin L. PalleikoCEO & Director | -10.94k | 144.66k | Derivative Exercise and Sale | 13.22 | 386.86k | - |
| 2025-08-17 | Dr. Paul K. AudhyaChief Medical Officer | 3.51k | 0.00 | Derivative Exercise and Retained Stock | - | 116.53k | 3.10% |
| 2025-08-17 | Dr. Paul K. AudhyaChief Medical Officer | -2.94k | 38.76k | Derivative Exercise and Sale | 13.19 | 116.53k | - |
| 2025-08-17 | Dr. Christopher M. YeaChief Development Officer | 1.55k | 0.00 | Derivative Exercise and Retained Stock | - | 129.49k | 1.21% |
| 2025-08-17 | Dr. Christopher M. YeaChief Development Officer | -2.65k | 34.93k | Derivative Exercise and Sale | 13.19 | 129.49k | - |
| 2025-08-17 | Mr. Benjamin L. PalleikoCEO & Director | 4.95k | 0.00 | Derivative Exercise and Retained Stock | - | 374.55k | 1.34% |
| 2025-08-17 | Mr. Benjamin L. PalleikoCEO & Director | -4.41k | 58.14k | Derivative Exercise and Sale | 13.19 | 374.55k | - |
| 2025-07-09 | Mr. Benjamin L. PalleikoCEO & Director | -32.98k | 517.52k | 売り | 15.69 | 369.60k | -8.19% |
| 2025-07-09 | Dr. Christopher M. YeaChief Development Officer | -30.25k | 474.70k | 売り | 15.69 | 127.94k | -19.12% |
| 2025-06-06 | Mr. Benjamin L. PalleikoCEO & Director | 8.46k | 0.00 | Derivative Exercise and Retained Stock | - | 315.07k | 2.76% |
| 2025-06-06 | Mr. Benjamin L. PalleikoCEO & Director | -7.17k | 103.95k | Derivative Exercise and Sale | 14.50 | 315.07k | - |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
